Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2S,4R)-4-18F-Fluoroglutamine

Overview of attention for article published in Frontiers in immunology, January 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter: 8 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 9 X posts from 8 X users, with an upper bound of 36,555 followers.

RT @l_tomas01: Nice to see our suggestion from 2018 of a Glutamine-Tracer in CVD put into action by @RoivainenAnne @InFLAMES_Health, congra…

16 Feb 2022

Reply Repost Favourite

Nice to see our suggestion from 2018 of a Glutamine-Tracer in CVD put into action by @RoivainenAnne @InFLAMES_Health, congrats! Looking forward to using this in the future at @LMU_Uniklinikum https://t.co/v3NEhPlM8I https://t.co/pz9ANeogCw

16 Feb 2022

Reply Repost Favourite

🔥Hottest @FrontImmunol articles this week #1 Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2S,4R)-4-18F-Fluoroglutamine. Palani S. et al. @UniTurku Read 👉 https://t.co/m1gjWM1UQK

28 Jan 2022

Reply Repost Favourite

RT @KaikkonenLab: Happy of this collaboration with @RoivainenAnne @AKA_ohjelmat where we exploit glutamine consumption to detect atheroscle…

27 Jan 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.